DEVOURED
The State of Longevity
The 'healthmaxxing' economy is moving mainstream, creating a massive opportunity for platforms that can bridge the gap between health data and actionable interventions.
What: A survey of 500 US consumers indicates growing interest in longevity tech, non-toxic products, and self-managed health. A16z analysts highlight that while general AI assistants provide health information, the real value lies in the 'action layer'—companies that handle lab testing, prescription fulfillment, and appointment scheduling.
Why it matters: The shift from passive health monitoring to proactive 'healthmaxxing' suggests a future where consumers prioritize services that offer specific, actionable improvements over those that just aggregate biometric data.
Deep dive
- Consumer shifts: Increased spending on non-toxic home goods and interest in experimental peptides.
- Healthcare home: A race is on to build the 'Muse for healthcare'—a single app that manages records, labs, wearables, and clinical intervention.
- Peptides: A transition from unregulated experimental compounds to FDA-regulated drugs with high consumer demand.
- Wearables (Act 3): A shift from step-counting to specific biomarker tracking (e.g., blood pressure, hormone patterns).
- Neurotech: Emerging non-invasive BCIs could soon allow consumers to modulate sleep, focus, and mood through neural stimulation.
Decoder
- Healthmaxxing: A cultural trend where individuals aggressively optimize their health through biohacking, supplements, and lifestyle changes to extend longevity.
Original article
Full article content is not available for inline reading.
Explore all 53 articles in today's digest
Fresh dev news, AI-digested daily. Never miss a trend at devoured.fyi